1Wacker P, Land V J, Camitta BM, et al. Allergic Reactions to E. coli L-Asparaginase Do Not Affect Outcome in Childhood B-precursor Acute Lymphoblastic Leukemia: A Children's Oncology Group Study [J]. J Pediatr Hematol Oncol, 2007, 29 (9) :627
2Wetzler M, Sanford BL, Kurtzberg J, et al. Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511[J]. Blood, 2007, 109 (10) :4164
3Top PC, Tissing WJ, Kuiper JW, et al. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage[ J]. Pediatr Blood Cancer, 2005,44 ( 1 ) :95
5Muller HJ, Beier R, Eoning L, et al. Pharmacokinetics of native Escherichiacoli Aspaaraginase( Asparaginase medac) and hypersensitivity reactions in ALL- BFM 95 reinduction treatment[ J]. Br J Haematol, 2001,114 : 794
6Zakarija A, Kwaan HC. Adverse effects on hemostatic function of drugs used in hematologic malignancies [ J ]. Semin Thromb Hemost, 2007,33 (4) :355
7Ruud E, Holmstrom H, de Lange C, et al. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000) : a single-institution study[ J]. Pediatr Hematol Oncol, 2006, 23 (3) :207
8Alves C, Chaves C, Souza M. Transient diabetes mellitus related to L-asparaginase therapy[J]. Arq Bras Endocrinol Metabol. 2007, 51 (4) :635
9Kieslich M, Porto L, Lanfermann H, et al. Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia[J]. J Pediatr Hematol Oncol, 2003, 25 (6) : 484
10Miyazawa Y, Irisawa H, Matsushima T, et al. Reversible posterior leukoencephalopathy syndrome probably caused by L-asparaginase [J]. Rinsho Ketsueki, 2006, 47 (6) : 531
2Boos J,Werber G,Ahlke E,et al.Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations.Eur J Cancer,1996,32A:1544-1550.
3Vieira Pinheiro JP,Lanversa C,Wurthwein G,et al.Drug monitoring of PEG-asparaginase treatment in childhood acute lymphoblastic leukemia and non-Hodgkin' s lymphoma.Leuk Lymphoma,2002,43:1911-1920.
4Rizzari C,Valsecchi MG,Arico M,et al.Effect of protracted highdose L-Asparaginase given as a second exposure in a Berlin-FrankfurtMunster-based treatment:results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione Italiana Ematologia Oncologia Pediatrica.J Clin Oncol,2001,19:1297-1303.
5Albertsen BK,Schroder H,Jakobsen P,et al.Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries.Br J Clin Pharmaco1,2001,52:433-437.
6Riccardi R,Holcenberg JS,Glaubiger DL,et al.L-Asparaginase pharmacokinetics and asparagines levels in cerebrospinal fluid of rhesus monkeys and humans.Cancer Res,1981,41:4554-4558.
